Leicestershire, United Kingdom

Eric Merifield

USPTO Granted Patents = 2 


Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Eric Merifield: Innovator in Pharmaceutical Processes

Introduction

Eric Merifield is a notable inventor based in Leicestershire, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on improving manufacturing processes for pharmaceutical compounds, showcasing his dedication to innovation in this critical industry.

Latest Patents

Merifield's latest patents include a pharmaceutical process and intermediates, which relates to compounds of formula (X) and their use as intermediates in improved manufacturing processes. The invention details specific compounds and their applications in synthesizing pharmaceutical compounds. Another significant patent is for a process for the preparation of substituted indoles, which are recognized for their therapeutic potential.

Career Highlights

Eric Merifield is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to leverage his expertise in pharmaceutical processes, contributing to the development of innovative therapeutic solutions.

Collaborations

Throughout his career, Merifield has collaborated with esteemed colleagues such as Philip Keegan and Duncan Gill. These partnerships have likely enhanced his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Eric Merifield stands out as a dedicated inventor in the pharmaceutical industry, with a focus on improving processes and developing therapeutic agents. His contributions through patents and collaborations reflect his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…